TNF and early-onset autosomal dominant Alzheimer disease: Specifically, Lut has been shown to inhibit inflammatory responses by reducing the expression of the pro-inflammatory cytokines tumor necrosis factor (TNF)-α, IL-1β, and IL-6 and has demonstrated efficacy in the treatment of neutrophilic asthma, lupus nephritis, and Alzheimer’s disease [26,27,28].